Related Experiment Video
Updated: Jun 26, 2026

09:14
Exploring the Neural Correlates of Cognitive Reappraisal in Obsessive-Compulsive Disorder Using Task-based Functional Magnetic Resonance Imaging
Published on: March 14, 2025
Using functional MRI neurofeedback to modulate self-blame in major depressive disorder: A pilot study.
Alex Nagle1, Alessandro Colasanti2, Roland Zahn3
1Department of Clinical Neuroscience, Brighton and Sussex Medical School, Brighton, England, United Kingdom.
Neuroimage. Clinical
|June 24, 2026
Summary
This pilot study explored functional magnetic resonance imaging (fMRI) neurofeedback targeting the subgenual cingulate cortex (SCC) for major depressive disorder (MDD). While safe and feasible, inconsistent brain activity regulation suggests further research is needed.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Imaging
Background:
- Major depressive disorder (MDD) is linked to self-blame neural networks.
- fMRI neurofeedback offers potential interventions for self-blame in MDD.
- Feasibility and mechanisms of neurofeedback for MDD require further investigation.
Purpose of the Study:
- To assess the feasibility and safety of a single-session SCC-targeted fMRI neurofeedback protocol in MDD patients.
- To explore potential mechanisms of SCC neurofeedback by comparing two intervention strategies.
- To gather preliminary data for designing future, larger-scale studies.
Main Methods:
- A pilot study used single-session fMRI neurofeedback targeting the subgenual cingulate cortex (SCC).
- Two interventions involved participants upregulating or downregulating SCC activity during guilt and indignation tasks.
- Ten participants were assigned to each intervention group (n=10 per group).
Main Results:
- Clinical scores improved across both interventions, with no significant difference between them.
- Neurofeedback performance was variable; significant group-level regulation was observed only for the indignation condition in Intervention B.
- Whole-brain analysis revealed no significant clusters surviving correction for multiple comparisons.
Conclusions:
- The SCC-oriented neurofeedback protocol is feasible and safe for individuals with MDD in a small sample.
- Inconsistent group-level target engagement suggests potential heterogeneity in SCC function related to agency.
- Preliminary data support further investigation with larger sample sizes and refined methodologies.
